Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subacute local tolerance of an ointment containing 0.5% neomycin sulfate (Myacyne Salbe)
2011-002284-14Phase 4Completed
- Sponsor
- Schur Pharmazeutika GmbH & Co. KG
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of neomycin in Not applicable (2 arms), sponsored by Schur Pharmazeutika GmbH & Co. KG. Primary endpoint: Local skin tolerance (use test). Started Nov 2011; status: completed.
02
Drugs
neomycin
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2011-002284-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002284-14.